Reimbursements

Column {data-width=650}

Top vendors

Gilead

Top product reimbursed by State

State Label Vendor Medicaid Paid
AK MAVYRET AbbVie Inc. $7,526,463
AL FOCALIN XR Novartis Pharmaceuticals Corporation $26,580,202
AR FOCALIN XR Novartis Pharmaceuticals Corporation $27,441,369
AZ MAVYRET AbbVie Inc. $39,361,497
CA ABILIFY Otsuka America Pharmaceuticals Inc. $402,645,829
CO HUMIRA PEN AbbVie Inc. $33,238,648
CT EPCLUSA 4 Gilead Sciences, Inc. $38,064,165
DC GENVOYA TA Gilead Sciences, Inc. $27,703,403
DE REMICADE Janssen Biotech, Inc. $441,530
FL GENVOYA Gilead Sciences, Inc. $69,940,884
GA METHYLPHEN SpecGx LLC $45,932,383
HI INVEGA SUS Janssen Pharmaceuticals, Inc. $8,240,455
IA FOCALIN XR Novartis Pharmaceuticals Corporation $7,343,680
ID LATUDA Sunovion Pharmaceuticals Inc. $6,872,713
IL HUMIRA - A AbbVie Inc. $79,791,099
IN Lyrica (pr Parke-Davis Div of Pfizer Inc $39,690,429
KS INVEGA SUS Janssen Pharmaceuticals, Inc. $8,030,921
KY MAVYRET AbbVie Inc. $58,730,254
LA VYVANSE Shire LLC $41,284,359
MA SUBOXONE 8 Indivior Inc. $73,358,404
MD GENVOYA TA Gilead Sciences, Inc. $36,075,640
ME SUBOXONE Indivior Inc. $13,540,720
MI LATUDA Sunovion Pharmaceuticals Inc. $78,752,958
MN HUMIRA PEN AbbVie Inc. $35,255,482
MO LATUDA Sunovion Pharmaceuticals Inc. $37,356,044
MS NOVOLOG 10 Novo Nordisk $9,520,571
MT HUMIRA 40 AbbVie Inc. $7,327,608
NC VYVANSE Shire LLC $54,168,043
ND NOVOLOG 10 Novo Nordisk $3,437,474
NE FOCALIN XR Novartis Pharmaceuticals Corporation $8,605,088
NH SUBOXONE Indivior Inc. $4,861,090
NJ HUMIRA - A AbbVie Inc. $48,746,835
NM MAVYRET 10 AbbVie Inc. $33,539,109
NV HUMIRA - A AbbVie Inc. $13,699,434
NY GENVOYA Gilead Sciences, Inc. $116,342,318
OH HUMIRA - A AbbVie Inc. $103,591,345
OK HUMIRA - A AbbVie Inc. $13,132,125
OR HUMIRA - A AbbVie Inc. $30,846,525
PA MAVYRET 10 AbbVie Inc. $126,225,742
RI HUMIRA - A AbbVie Inc. $10,941,014
SC VYVANSE Shire LLC $24,309,032
SD ARANESP (d Amgen Inc $2,669,794
TN VYVANSE Shire LLC $31,885,976
TX NORDITROPI Novo Nordisk $60,011,161
UT INVEGA SUS Janssen Pharmaceuticals, Inc. $7,215,932
VA ONDANSETRO Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. $22,637,386
VT Suboxone S Indivior Inc. $17,445,893
WA HUMIRA - A AbbVie Inc. $69,119,825
WI HUMIRA - A AbbVie Inc. $52,716,986
WV SUBOXONE 8 Indivior Inc. $37,003,078
WY HUMIRA - A AbbVie Inc. $1,508,235

Reimbursement breakdown by type of care

Column

Top 15 drugs (in dollar amount) reimbursed by Medicaid across all States

Label Medicaid Paid Non-Medicaid Paid Total Reimbursements
HUMIRA 40 $1,707,478,371 $11,580,403 $1,719,058,774
MAVYRET 10 $1,657,688,346 $1,983,794 $1,659,672,140
METHYLPHEN $1,165,440,281 $32,921,367 $1,198,361,648
INVEGA SUS $1,161,877,422 $12,973,868 $1,174,851,290
FLOVENT HF $1,148,514,719 $20,344,059 $1,168,858,778
VENTOLIN H $1,037,910,134 $6,082,060 $1,043,992,194
GENVOYA TA $1,022,565,800 $4,872,160 $1,027,437,960
SYMBICORT $949,856,775 $9,811,423 $959,668,198
UNKNOWN $907,815,652 $81,628,364 $989,444,016
HUMALOG 10 $860,198,372 $23,581,226 $883,779,598
SUBOXONE 8 $846,395,095 $5,353,623 $851,748,718
HUMIRA - A $839,869,552 $7,472,786 $847,342,338
HUMIRA PEN $815,359,288 $4,132,718 $819,492,006
PROAIR HFA $797,866,520 $11,395,903 $809,262,423
GENVOYA $790,877,220 $4,628,794 $795,506,014

Clustering check

Column

Correlation-based clustering

Cluster tendency

Determine k: WSS method

Determine k: Silhouette method

Cluster analysis

Column {data-width=350}

Clusters by State (k = 4)

k-means table

Cluster Medicaid Paid Prescriptions Units reimbursed Total reimbursed Fee-for-Service Managed Care
1 $248,566,206 3,237,227 207,890,170 $267,367,206 9,899 13,406
2 $5,999,992,267 87,479,007 5,296,480,177 $7,244,277,296 42,666 63,656
3 $996,511,064 10,354,094 630,818,099 $1,032,195,797 32,570 3,594
4 $1,799,141,612 22,823,271 1,364,962,160 $1,857,138,798 17,414 41,217

Column {data-width=350}

Clusters by State (k = 2)

k-means table

Cluster Medicaid Paid Prescriptions Units reimbursed Total reimbursed Fee-for-Service Managed Care
1 $4,076,952,128 53,140,704 3,306,489,368 $4,560,281,645 26,586 54,515
2 $727,880,351 9,031,114 535,688,923 $757,273,729 17,344 17,648